In this study, we found that in obesity, the hyperinsulinemia presumably downregulates MΦ Irs2 expression, resulting in impaired IL-4-induced M2a-subtype MΦ activation, and consequently, development of inflammation and insulin resistance in the liver and WAT. The gene discussed is IRS2; the disease is Hyperinsulinemia.